On May 15th, the 11th session of the "Pusoft Industry Channel" medical robot special session - "How Intelligent Medical Robots Help the Medical and Health Industry" was broadcast on time on the China Enterprise Video platform of China Enterprise Daily. The four heavyweight guests not only shared the application and popularization status of medical robots, but also deeply analyzed the global pattern of the industry, and proposed to build the originality of China's intelligent medical robots, paving the way for the global rise of China's smart healthcare; At the same time, he emphasized the importance of industry linkage, and discussed how to use the platform effect to jointly promote the overall competitiveness of China's medical and health industry, accelerate the internationalization process of China's smart healthcare, and help China occupy a leading position in the global medical and health field.
In the wave of technological innovation and industrial transformation, medical robots, as a disruptive technology, are profoundly reshaping the future of the traditional medical and health industry with its unique application potential and extensive practical value. The 11th special plan of the "Pusoft Industry Channel" - the special session of medical robots brought together leaders in medical engineering and technological innovation to jointly draw a grand blueprint for intelligent medical robots to help the development of the medical and health industry.
Zhang Yuming, the founder of the 101 Medical Engineering Innovation Consortium, Cheng Yunzhang, Dean and Professor of the School of Medical Devices of the University of Shanghai for Science and Technology, He Chao, CEO of Shanghai Minimally Invasive Medical Robot (Group) Co., Ltd., and Pan Jing, Chairman of Shanghai Timi Robot Co., Ltd., four outstanding representatives from academia and business, deeply analyzed the development trend and practical application of intelligent medical robots from different perspectives. The event attracted more than 54,000 people to watch online through the China Enterprise Daily China Enterprise Video platform, which sparked extensive discussion and resonance in the medical and health industry, and is of great strategic significance for promoting the innovation and integration of medical robot technology and accelerating the intelligent process of the medical and health industry.
At the beginning of the new season, the "Pusoft Industry Channel" promotes the wave of digital industry
"Pusoft Industry Channel" is an online platform built by the Industrial Service Competence Center of Shanghai Pudong Software Park, aiming to further promote the "Pusoft" brand and serve the construction and development of the park's modern industrial system. Since its launch on August 9, 2023, ten episodes of the program have been successfully broadcast, focusing on hot topics such as the metaverse, data security, large models, low-altitude economy, digital transformation of enterprises, digital technology and medical health, etc., attracting more than 500,000 online viewers, becoming an important medium to promote the park's "bringing in" and "going out" strategies.
The "Pusoft Industry Channel" not only provides a platform for enterprises in the park to show their strength, but also promotes exchanges and cooperation between enterprises, and provides valuable learning opportunities for enterprises. With the opening of the new season on May 15, the 2024 "Pusoft Industry Channel" will continue to invite industry experts, business leaders, industry researchers and other guests to participate in the event to share the cutting-edge trends, innovative ideas and successful experiences of the digital industry development online through the CEV platform.
Cheng Yunzhang: Domestic intelligent medical robots usher in new business opportunities
As the first speaker of this program, Professor Cheng Yunzhang, Dean of the School of Medical Devices of the University of Shanghai for Science and Technology and Academician of the European Academy of Natural Sciences, shared the current development status of the medical robot industry, the trend of intelligent medical robots and the development opportunities faced by domestic medical robots.
The medical robot industry chain is complex, covering from upstream basic industries such as new materials, key mechanical parts, software and digital technology, to downstream market application scenarios. Although the industrial chain is complicated, Professor Cheng Yunzhang is very optimistic. "The medical robot industry has benefited from favorable policies, accelerated approvals, growing demand for robots in hospitals, and medical insurance policies have also supported it. We are in a critical period of independent innovation and clinical application promotion, and the market potential is huge, especially in the field of surgical robots and rehabilitation robots. ”
The medical robot industry is a high-tech field that integrates multiple disciplines such as medicine and engineering, covering multiple technical directions such as machinery, electronics, materials, and information. "There are many kinds of medical robots, among which the development trend of surgical robots is manifested in the continuous satisfaction of clinical needs, and the rapid development of domestic surgical robot enterprises and the continuous enhancement of competitiveness." Professor Cheng Yunzhang pointed out the direction of industrial development based on medical practice: "In the future, the medical robot industry will develop in the direction of miniaturization, intelligence and remoteness. ”
Professor Cheng Yunzhang is optimistic about the domestic medical robot industry, "its development opportunity lies in the fact that the complete domestic industrial system has laid the foundation for the medical robot industry, and at the same time, the successful cases of overseas giants provide us with valuable experience and clinical evidence." With the popularization of laparoscopic surgery, the marginal cost of surgical robots has been reduced, and the market potential is huge. The guidance and standardization of policies will promote the healthy development of surgical robots, encourage innovation, and improve clinical value. In the face of challenges, enterprises need to rely on their own innovation capabilities and hematopoietic capabilities, attach importance to clinical use value, and realize the automation of core operations in the whole process. The real innovation comes from a large number of clinical trials and operations, and with the unremitting efforts of domestic entrepreneurs, we are expected to catch up and surpass in the field of surgical robots. ”
He Chao: Medical robots make remote surgery possible
Surgical robots are known as the third surgical revolution, through robot flexible control technology, stereo vision technology and other advanced technologies, so that difficult cancer surgeries can be completed in a minimally invasive way, and the performance of complex surgeries has been comprehensively improved. As the founder and CEO of Shanghai Minimally Invasive Medical Robot (Group) Co., Ltd. and the director of Shanghai Minimally Invasive Surgical Robot Engineering Center, Dr. He Chao shared his own experience on the technological innovation, application scenarios and development trends of surgical robots.
"From the perspective of the international market, the surgical robot industry has been very mature." There are more than 8,000 robots serving patients worldwide, with a cumulative surgeon volume of more than 14 million surgeries. "However, an obvious problem is that foreign products have monopolized the global market for more than 20 years. Only by developing high-quality domestic surgical robots can we truly make our medical institutions affordable and useful, realize the quality of medical treatment, and benefit the people! ”
Surgical robots are one of the most technically complex and commercially valuable areas of medical devices. For example, a surgical robotic system consists of more than 13,000 parts, and it integrates global resources: including optical technology from Germany, control algorithms and hardware technology from the United States, software technology from IBM, and image processing technology from Japan. "It is encouraging that the national policy has given a lot of support to surgical robots, and it has been listed as a strategic emerging industry supported by the state in China's high-end medical device category." As a practitioner, Dr. He Chao feels this deeply. "I have been researching surgical robots since 2007 and am one of the first batch of surgical robot researchers in the country. In the past ten years, our minimally invasive robots have made breakthroughs in various directions such as laparoscopy, bone and joint, vascular intervention, natural orifice and puncture. We are pleased to see that China's surgical robot industry, represented by minimally invasive robots, has been at the top level in the world in terms of breadth of coverage, depth of research and innovation. ”
Technical strength enhances industrial advantages. "We successfully exported to overseas and obtained FDA approval to enter the U.S. market, becoming the first surgical robot product exported to overseas markets in mainland China. At present, we have installed capacity in Europe, North America, Australia, Latin America and other countries, and the total installed capacity and surgical volume have exceeded that of China. ”
Pan Jing: Robotics + artificial intelligence to build intelligent medical solutions
Timi Robot Co., Ltd. is a high-tech enterprise focusing on the field of medical robots, and unlike surgical robots that are generally concerned in the market, Timi Robotics has chosen a development path of its own.
Pan Jing, chairman of the board of directors, introduced, "Starting from the original needs of medical workflow, Timi is committed to solving the core problems of the medical supply side. "In the seven years since its establishment, Tiami has achieved global independent innovation in the field of non-surgical assisted medical treatment, and has made breakthroughs from zero to one." In this process, we have no precedent to follow, and we have developed more than 50 different forms of medical robot products by relying entirely on our in-depth understanding of clinical, scientific research, teaching, management and other dimensions of medical institutions. At present, these products have been successfully applied to nearly 500 large tertiary hospitals in China. ”
Clinical innovation is notoriously slow and varies widely across segments. However, the initial application of robotics in industrial scenarios is essentially to achieve standardization and consistency in product production. The technological innovation of Timi Robot is combined with hospital management practice to realize the replicability of the entire system in medical scenarios. Provide complete intelligent solutions for the ten major medical scenarios of hospitals, including operating rooms, outpatient clinics, wards, imaging centers, etc. "We have integrated digital twin technology, robotics, 5G, artificial intelligence and Internet of Things technologies to achieve clinical research innovation for medical institutions, and expand limited medical resources through intelligent medical equipment, so that more people can enjoy better medical services."
Round Table: The platform works together to go to sea with wisdom
Since the beginning of reform and opening up, Chinese enterprises have begun to try to go abroad and explore the international market. This period is characterized by the export of low-end products, known as the 1.0 stage, and then with China's accession to the World Trade Organization (WTO), Chinese enterprises entered the 2.0 stage, introduced the strategy of going out, accelerated the pace of going overseas, and began to participate in international cooperation and competition on a larger scale; In the 3.0 stage, Chinese enterprises going overseas focus on global layout and brand building, and acquire international advanced technology and management experience through mergers and acquisitions, joint ventures, etc., so as to enhance brand value and international competitiveness; At the current stage, Chinese enterprises have entered a new 4.0 stage, and they pay more attention to innovation-driven, brand building and digital transformation, strengthen R&D investment, and enhance their core competitiveness through innovation. The export of medical devices and equipment has gone through the same process, and now digital intelligent medical equipment has broad prospects as an emerging field. During the roundtable discussion, Zhang Yuming, the initiator of the 101 Medical Engineering Innovation Consortium, received a positive response from Professor Cheng Yunzhang as soon as he raised the topic of digital intelligent medical equipment going overseas. "The demand for medical robots in overseas markets has a very broad prospect, especially in the countries along the "Belt and Road", where there is a certain gap between medical equipment and the mainland, and there is a huge demand for high-level surgical robots. ”
Professor Cheng Yunzhang recently visited countries along the "Belt and Road" and deeply realized the urgent need for advanced medical robots in these regions. "The product line of minimally invasive medical robots is very broad and has successfully entered the US market. In addition to Central and Southeast Asian countries, these products also have huge market potential in countries along the Belt and Road. In addition, Professor Cheng Yunzhang mentioned a mission he brought back during his visit to Kazakhstan, "The local demand for high-level medical equipment is very strong, and I hope we can bring high-quality medical equipment to them for technical exchanges and cooperation." Through such international cooperation and exchanges, we can bring the advanced technology of domestic surgical robots to more places where the world needs them, and at the same time open up a new path for the international development of China's medical robot industry. ”
Dr. He Chao focused on sharing the great prospects of 5G telemedicine technology. "Remote surgical technology is the pride of China's medical robot technology, which has not only been applied in China, but also recognized by the international market. Due to the uneven level of medical care, remote surgery technology has also shown great potential for application in countries along the Belt and Road. In these areas, due to the lack of highly qualified medical specialists, telesurgery can provide timely and effective treatment to local patients, while helping local doctors improve their surgical skills and medical conditions. "Of course, there are challenges to the promotion and application of remote surgery. Support in terms of technology, equipment, network, and policy is indispensable. In addition, companies need to establish cooperation with local medical institutions to jointly explore remote surgery models suitable for local conditions.
Pan Jing proposed that the future of medical equipment includes a new generation of technologies such as the Internet of Things, big data, artificial intelligence, and robotics to build a new medical ecosystem. This provides a new development direction and "going global" opportunities for medical companies. "China's healthcare system needs special solutions to meet its unique challenges. Through innovation, solutions can be found that meet domestic needs and have the potential to be internationalized. ”
In this process, the role of the joint innovation platform cannot be ignored. Professor Cheng Yunzhang pointed out that at present, with the country's emphasis on technology development trends, artificial intelligence and big data are being integrated into various fields of the medical industry to achieve medical digitalization and intelligence. He stressed that if enterprises want to go global and enter the markets of the Belt and Road Initiative or SCO countries, they need a platform like the 101 Medical Engineering Innovation Consortium to empower medical equipment companies in Pudong and the city. ”
Zhang Yuming also said, "In the context of smart medical innovation and development and Chinese enterprises going overseas, the 101 platform was born at the right time, aiming to promote technological innovation and product upgrading in the field of medical engineering, especially for medical equipment enterprises in Pudong, Shanghai and even the whole country, especially those enterprises with innovative capabilities in the field of artificial intelligence and robotics. Expand overseas business opportunities. ”
With a new round of technological revolution and industrial transformation, the application and popularization of medical robots are changing the traditional medical and health industry. This online forum not only showcased China's originality in the field of medical robotics and smart medicine, but also promoted exchanges and cooperation inside and outside the industry through the role of a platform, and at the same time provided important information for participating companies to gain insight into the international market and grasp business opportunities overseas.
In the future, the "Pusoft Industry Channel" will continue to invite industry experts, business leaders, industry researchers and other guests to participate in the event to share the cutting-edge trends, innovative ideas and successful experiences of the development of the digital industry. As a business card of Shanghai Pudong Software Park, the "Pusoft Industry Channel" has become an important force to promote the digital transformation of enterprises in the park and promote industrial upgrading. The new quarter of 2024 will bring more innovative resources, drive wider social influence, and make greater contributions to the development of the digital industry in the park and even the whole country. (Text/China Enterprise Jun)